Concepts (74)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diffusion Magnetic Resonance Imaging | 5 | 2021 | 2823 | 1.310 |
Why?
|
Multiple System Atrophy | 1 | 2023 | 129 | 0.760 |
Why?
|
Free Tissue Flaps | 1 | 2024 | 337 | 0.670 |
Why?
|
Trigeminal Nerve | 1 | 2020 | 248 | 0.640 |
Why?
|
Radiology | 2 | 2023 | 2118 | 0.610 |
Why?
|
Sarcopenia | 1 | 2023 | 376 | 0.600 |
Why?
|
Edema | 2 | 2023 | 766 | 0.570 |
Why?
|
Nerve Fibers | 1 | 2020 | 708 | 0.550 |
Why?
|
Glioma | 4 | 2025 | 3523 | 0.490 |
Why?
|
Head and Neck Neoplasms | 2 | 2023 | 2915 | 0.400 |
Why?
|
Phantoms, Imaging | 1 | 2020 | 2528 | 0.390 |
Why?
|
Brain Neoplasms | 4 | 2025 | 9182 | 0.320 |
Why?
|
Diffusion Tensor Imaging | 5 | 2023 | 2427 | 0.290 |
Why?
|
Glioblastoma | 1 | 2020 | 3523 | 0.240 |
Why?
|
Multiple Sclerosis | 1 | 2020 | 3245 | 0.240 |
Why?
|
Models, Biological | 1 | 2020 | 9505 | 0.230 |
Why?
|
Temporal Muscle | 1 | 2023 | 36 | 0.220 |
Why?
|
Growth Charts | 1 | 2023 | 60 | 0.210 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4906 | 0.210 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2020 | 9066 | 0.210 |
Why?
|
Optic Neuritis | 1 | 2021 | 175 | 0.160 |
Why?
|
Prostatic Neoplasms | 1 | 2021 | 11206 | 0.150 |
Why?
|
Atrophy | 1 | 2023 | 1648 | 0.150 |
Why?
|
Fatty Liver | 1 | 2024 | 807 | 0.150 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2023 | 493 | 0.140 |
Why?
|
Multiple Sclerosis, Chronic Progressive | 1 | 2019 | 256 | 0.140 |
Why?
|
Anisotropy | 1 | 2020 | 1296 | 0.140 |
Why?
|
Monitoring, Physiologic | 1 | 2024 | 1795 | 0.130 |
Why?
|
Artificial Intelligence | 3 | 2024 | 2659 | 0.120 |
Why?
|
Corpus Callosum | 1 | 2019 | 755 | 0.120 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14728 | 0.120 |
Why?
|
Neuroprotective Agents | 1 | 2021 | 960 | 0.120 |
Why?
|
Natural Language Processing | 1 | 2023 | 1197 | 0.120 |
Why?
|
Multiple Sclerosis, Relapsing-Remitting | 1 | 2019 | 558 | 0.110 |
Why?
|
Humans | 20 | 2025 | 768451 | 0.110 |
Why?
|
ROC Curve | 1 | 2021 | 3624 | 0.100 |
Why?
|
Magnetic Resonance Imaging | 3 | 2025 | 36840 | 0.100 |
Why?
|
Neural Pathways | 1 | 2023 | 3122 | 0.100 |
Why?
|
Female | 13 | 2025 | 396943 | 0.100 |
Why?
|
Carcinoma | 1 | 2023 | 2341 | 0.100 |
Why?
|
Papillomavirus Infections | 1 | 2023 | 1638 | 0.090 |
Why?
|
Male | 11 | 2025 | 364781 | 0.090 |
Why?
|
Radiography | 1 | 2021 | 6995 | 0.080 |
Why?
|
Parkinson Disease | 1 | 2023 | 2891 | 0.080 |
Why?
|
Liver | 1 | 2024 | 7575 | 0.080 |
Why?
|
Brain Mapping | 1 | 2023 | 6740 | 0.070 |
Why?
|
Retrospective Studies | 6 | 2025 | 81834 | 0.070 |
Why?
|
Algorithms | 3 | 2023 | 14158 | 0.070 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2025 | 9425 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20231 | 0.060 |
Why?
|
Mice, Inbred C57BL | 2 | 2021 | 22365 | 0.060 |
Why?
|
Child | 5 | 2025 | 80863 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20762 | 0.060 |
Why?
|
Middle Aged | 4 | 2023 | 223418 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 5426 | 0.050 |
Why?
|
Substantia Nigra | 1 | 2023 | 348 | 0.050 |
Why?
|
Adolescent | 3 | 2025 | 89168 | 0.040 |
Why?
|
Aged | 3 | 2020 | 171520 | 0.040 |
Why?
|
Lung Neoplasms | 1 | 2022 | 13589 | 0.040 |
Why?
|
Adult | 3 | 2020 | 223542 | 0.040 |
Why?
|
Mice | 2 | 2021 | 82045 | 0.030 |
Why?
|
Brain | 1 | 2023 | 27438 | 0.030 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2024 | 2072 | 0.030 |
Why?
|
Prognosis | 2 | 2025 | 30028 | 0.030 |
Why?
|
Infant | 2 | 2025 | 36497 | 0.030 |
Why?
|
Animals | 2 | 2021 | 169418 | 0.020 |
Why?
|
Child, Preschool | 2 | 2025 | 42623 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2021 | 1816 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2024 | 3408 | 0.020 |
Why?
|
Survival Rate | 1 | 2025 | 12875 | 0.020 |
Why?
|
Risk Assessment | 1 | 2025 | 24311 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2025 | 39430 | 0.010 |
Why?
|
Young Adult | 1 | 2024 | 60045 | 0.010 |
Why?
|
United States | 1 | 2022 | 73121 | 0.010 |
Why?
|
Concepts
(74)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(39)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_